Distinguishing Mechanisms From Markers of Cardiac Contractile Dysfunction More Than 1 Way to Skin the Cat of Heart Failure

作者: C. William Balke , Yibin Wang

DOI: 10.1161/01.CIR.101.7.738

关键词:

摘要: The incidence of death from cardiac hypertrophy and heart failure has increased steadily over the past 25 years despite overall decline in mortality disease during same period. As 1990, was responsible for more than 400 000 deaths per year most common discharge diagnosis Medicare population.1 Overall, patients with have a 5-year rate 50%. Patients New York Heart Association class III IV 2-year approaching 50% nearly optimal treatment ACE inhibitors, diuretics, digoxin.2 Therefore, it is fair to say that prevalence reached epidemic proportions this country industrialized western societies. Clearly, better understanding primary mechanisms underlie contractile abnormalities failing needed develop new therapeutic strategies existing effective guidelines prevention failure. After 3 decades intensive investigation, precise remain elusive. distinction between true mere markers been particularly difficult failure, because complex cascade physiological, neurohumoral, biochemical undoubtedly represents interaction multitude environmental genetic factors. Obviously, making far-reaching implications. Fresh insights regarding cellular molecular bases come very …

参考文章(18)
Kenneth R Chien, Stress pathways and heart failure. Cell. ,vol. 98, pp. 555- 558 ,(1999) , 10.1016/S0092-8674(00)80043-4
Ana Maria Gómez, HH Valdivia, H Cheng, Miriam R Lederer, Luis Fernando Santana, MB Cannell, SA McCune, RA Altschuld, WJ Lederer, None, Defective excitation-contraction coupling in experimental cardiac hypertrophy and heart failure. Science. ,vol. 276, pp. 800- 806 ,(1997) , 10.1126/SCIENCE.276.5313.800
W. Koch, H. Rockman, P Samama, R. Hamilton, R. Bond, C. Milano, R. Lefkowitz, Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor. Science. ,vol. 268, pp. 1350- 1353 ,(1995) , 10.1126/SCIENCE.7761854
Michael Lindner, Erland Erdmann, Dirk J. Beuckelmann, Calcium Content of the Sarcoplasmic Reticulum in Isolated Ventricular Myocytes from Patients with Terminal Heart Failure Journal of Molecular and Cellular Cardiology. ,vol. 30, pp. 743- 749 ,(1998) , 10.1006/JMCC.1997.0626
Susumu Minamisawa, Masahiko Hoshijima, Guoxiang Chu, Christopher A Ward, Konrad Frank, Yusu Gu, Maryann E Martone, Yibin Wang, John Ross, Evangelia G Kranias, Wayne R Giles, Kenneth R Chien, Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy. Cell. ,vol. 99, pp. 313- 322 ,(1999) , 10.1016/S0092-8674(00)81662-1
H He, F J Giordano, R Hilal-Dandan, D J Choi, H A Rockman, P M McDonough, W F Bluhm, M Meyer, M R Sayen, E Swanson, W H Dillmann, Overexpression of the rat sarcoplasmic reticulum Ca2+ ATPase gene in the heart of transgenic mice accelerates calcium transients and cardiac relaxation Journal of Clinical Investigation. ,vol. 100, pp. 380- 389 ,(1997) , 10.1172/JCI119544
Kimberly L. Koss, Evangelia G. Kranias, Phospholamban: A Prominent Regulator of Myocardial Contractility Circulation Research. ,vol. 79, pp. 1059- 1063 ,(1996) , 10.1161/01.RES.79.6.1059
G. W. Dorn, N. M. Tepe, J. N. Lorenz, W. J. Koch, S. B. Liggett, Low- and high-level transgenic expression of β2-adrenergic receptors differentially affect cardiac hypertrophy and function in Gαq-overexpressing mice Proceedings of the National Academy of Sciences of the United States of America. ,vol. 96, pp. 6400- 6405 ,(1999) , 10.1073/PNAS.96.11.6400
Ulrich Schmidt, Federica del Monte, Michael I. Miyamoto, Takashi Matsui, Judith K. Gwathmey, Anthony Rosenzweig, Roger J. Hajjar, Restoration of Diastolic Function in Senescent Rat Hearts Through Adenoviral Gene Transfer of Sarcoplasmic Reticulum Ca2+-ATPase Circulation. ,vol. 101, pp. 790- 796 ,(2000) , 10.1161/01.CIR.101.7.790
Markus Meyer, Wolfgang H Dillmann, Sarcoplasmic reticulum Ca2+-ATPase overexpression by adenovirus mediated gene transfer and in transgenic mice Cardiovascular Research. ,vol. 37, pp. 360- 366 ,(1998) , 10.1016/S0008-6363(97)00270-8